LYTIR

Company · ARQT

Arcutis Biotherapeutics, Inc.

Nasdaq's symbol directory lists ARQT on Nasdaq as “Arcutis Biotherapeutics, Inc. - Common stock”.

In the 12 months to Nov 19, 2026: insiders sold on 22 occasions ($4.4M); 9 planned-sale notices; 4 filings by holders of 5% or more; 3 congressional trade disclosures; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $4.4M in total.Jun: Insider sales $237KJul: Insider sales $127KAug: Insider sales $1.7MSep: Insider sales $456KOct: Insider sales $127KNov: Insider sales $1.7MDecJanFebMarAprMayJunJulAugSepOctNov$1.7M
Insider purchases above the line: $0Insider sales below: $4.4M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Masaru Matsuda, EVP, Chief Legal Officer sold on 5 days all under a 10b5-1 plan latest Nov 4, 2026 sold $1.8M
  2. Curran Terrie sold on 2 days latest Aug 27, 2026 sold $984K
  3. Welgus Howard G. sold on 7 days all under a 10b5-1 plan latest Nov 16, 2026 sold $742K
  4. Burnett Patrick, EVP, Chief Medical Officer sold on 5 days 1 of them under a 10b5-1 plan latest Nov 2, 2026 sold $496K
  5. Watanabe Todd, Reporting Person's title: President and Chief Executive Officer sold on 2 days 1 of them under a 10b5-1 plan latest Nov 2, 2026 sold $254K
  6. LIN SUE-JEAN sold on 1 day all under a 10b5-1 plan latest Jun 15, 2026 sold $121K
Every trade (22)
  1. SELLWelgus Howard G. sold Nov 16, 2026 4,728 shares 10b5-1 plan (scheduled) filing $133K
  2. SELLMasaru Matsuda, EVP, Chief Legal Officer sold Nov 4, 2026 40,000 shares 10b5-1 plan (scheduled) filing $1.4M
  3. SELLWatanabe Todd, Reporting Person's title: President and Chief Executive Officer sold Nov 2, 2026 4,377 shares filing $139K
  4. SELLMasaru Matsuda, EVP, Chief Legal Officer sold Nov 2, 2026 1,219 shares 10b5-1 plan (scheduled) filing $39K
  5. SELLBurnett Patrick, EVP, Chief Medical Officer sold Nov 2, 2026 943 shares filing $30K
  6. SELLWelgus Howard G. sold Oct 15, 2026 4,728 shares 10b5-1 plan (scheduled) filing $127K
  7. SELLMasaru Matsuda, Reporting Person's title: EVP, Chief Legal Officer sold Sep 16, 2026 3,674 shares 10b5-1 plan (scheduled) filing $92K
  8. SELLWelgus Howard G. sold Sep 15, 2026 4,730 shares 10b5-1 plan (scheduled) filing $114K
  9. SELLMasaru Matsuda, Reporting Person's title: EVP, Chief Legal Officer sold Sep 8, 2026 9,989 shares 10b5-1 plan (scheduled) filing $250K
  10. SELLCurran Terrie sold Aug 27, 2026 38,200 shares 2 legs combined filing $956K
  11. SELLCurran Terrie sold Aug 20, 2026 1,072 shares filing $28K
  12. SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold Aug 19, 2026 1,697 shares filing $46K
  13. SELLWelgus Howard G. sold Aug 17, 2026 4,730 shares 10b5-1 plan (scheduled) filing $124K
  14. SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold Aug 12, 2026 6,700 shares filing $175K
  15. SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold Aug 11, 2026 8,300 shares filing $220K
  16. SELLWatanabe Todd, Reporting Person's title: President and Chief Executive Officer sold Aug 3, 2026 4,375 shares 10b5-1 plan (scheduled) filing $114K
  17. SELLMasaru Matsuda, Reporting Person's title: EVP, Chief Legal Officer sold Aug 3, 2026 1,230 shares 10b5-1 plan (scheduled) filing $32K
  18. SELLBurnett Patrick, Reporting Person's title: EVP, Chief Medical Officer sold Aug 3, 2026 955 shares 10b5-1 plan (scheduled) filing $25K
  19. SELLWelgus Howard G. sold Jul 15, 2026 4,730 shares 10b5-1 plan (scheduled) filing $127K
  20. SELLWelgus Howard G. sold Jun 17, 2026 635 shares 10b5-1 plan (scheduled) filing $16K
  21. SELLLIN SUE-JEAN sold Jun 15, 2026 4,946 shares 10b5-1 plan (scheduled) filing $121K
  22. SELLWelgus Howard G. sold Jun 15, 2026 4,096 shares 10b5-1 plan (scheduled) filing $100K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Howard Welgus filed Nov 16, 2026 Director 4,728 shares planned sale date 11/16/2026 filing $133K
  2. Masaru Matsuda filed Nov 4, 2026 Officer 40,000 shares planned sale date 11/04/2026 filing $1.4M
  3. Todd Franklin Watanabe filed Nov 2, 2026 Officer 4,377 shares planned sale date 11/02/2026 filing $139K
  4. Masaru Matsuda filed Nov 2, 2026 Officer 1,219 shares planned sale date 11/02/2026 filing $39K
  5. Patrick Burnett filed Nov 2, 2026 Officer 943 shares planned sale date 11/02/2026 filing $30K
  6. Larry Todd Edwards filed Oct 20, 2026 Former Officer 60,376 shares planned sale date 10/20/2026 filing $2.0M
  7. Howard Welgus filed Oct 15, 2026 Director 4,728 shares planned sale date 10/15/2026 filing $127K
  8. Larry Todd Edwards filed Sep 16, 2026 Former Officer 341,980 shares planned sale date 09/16/2026 filing $8.5M
  9. Howard Welgus filed Sep 15, 2026 Director 4,730 shares planned sale date 09/15/2026 filing $114K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. STATE STREET CORPORATION filed Nov 10, 2026 Schedule 13G passive 7,718,628 shares filing 6.1%
  2. BlackRock, Inc. filed Oct 5, 2026 Schedule 13G/A passive 17,751,435 shares filing 14.1%
  3. Polar Capital Holdings Plc filed Aug 14, 2026 Schedule 13G passive 6,606,945 shares filing 5.28%
  4. STATE STREET CORPORATION filed Aug 7, 2026 Schedule 13G passive 5,822,840 shares filing 4.7%

Congress · STOCK Act

The Althing

Periodic transaction reports. Amounts are the ranges members report; the trade date is when it happened, the report can come up to 45 days later.

  1. Gilbert Cisneros (D-CA31): Purchase May 29, 2026 reported Jun 8, 2026 one of 103 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  2. Gilbert Cisneros (D-CA31): Purchase Mar 3, 2026 reported Apr 7, 2026 one of 141 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000
  3. Gilbert Cisneros (D-CA31): Sale Dec 11, 2025 reported Jan 12, 2026 one of 121 trades the member reported that day House Stocks (including ADRs) $1,001 - $15,000

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 4, 2026
  2. Departure or appointment of directors or officers; Regulation FD disclosure filing Oct 28, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.